BLUE


bluebird bio Inc (BLUE) Leads the Way in the Next Wave of CAR-Ts

Cowen analyst Eric Schmidt is out today with a research note on shares of bluebird bio Inc (NASDAQ:BLUE), following updated data from the company’s Phase …

Company Update (NASDAQ:BLUE): bluebird bio Inc and apceth Biopharma Announces Commercial Drug Product Manufacturing Agreement

bluebird bio Inc (NASDAQ:BLUE) and apceth Biopharma announced today that they have entered into a strategic manufacturing agreement providing for the future European …

Company Update (NASDAQ:BLUE): bluebird bio Announces First Patient Treated with LentiGlobinTM Drug Product in Phase 3 Trial of Patients with Transfusion-Dependent β-Thalassemia

bluebird bio Inc (NASDAQ: BLUE) announced treatment of the first patient in Northstar-2, the Phase 3 study of its LentiGlobin drug product in …

Roth Capital Sees Room for Optimism Following bluebird bio Inc (BLUE) ASH Read-Out

During last week’s American Society of Hematology (ASH) Annual Meeting and Exposition in San Diego, bluebird bio Inc (NASDAQ:BLUE) provided clinical updates on …

Stock Update (NASDAQ:BLUE): Bluebird Bio Inc Announces Pricing of Public Offering of Common Stock

bluebird bio Inc (NASDAQ:BLUE) announced the pricing of an underwritten public offering of 3,289,473 shares of its common stock at a public offering …

Stock Update (NASDAQ:BLUE): Bluebird Bio Inc Announces Proposed Public Offering of Common Stock

bluebird bio Inc (NASDAQ:BLUE) announced that it has commenced an underwritten public offering of $200 million of its common stock. bluebird bio also …

Merrill Lynch Offer Commentary On Bluebird Bio Inc (BLUE) Following Phase 1 Results In Relapsed/Refractory Multiple Myeloma

bluebird bio Inc (NASDAQ:BLUE) just announced Phase 1 results of bb2121, the BCMA CAR-T therapy, in patients with relapsed /refractory multiple myeloma that …

Company Update (NASDAQ:BLUE): Bluebird Bio Inc Names New Chief Operating Officer and Head of Europe

bluebird bio Inc (NASDAQ:BLUE) announced two new appointments as part of the company’s ongoing preparation for commercial readiness. Susanna High was named chief …

Roth Capital Reacts to Rollercoaster Biotech Players: Heat Biologics Inc (HTBX), bluebird bio Inc (BLUE)

The biotech-verse is in full upheaval mode as Heat Biologics Inc (NASDAQ:HTBX) shares nosedive following disheartening Phase II results in bladder cancer and …

BTIG Dives in on Bluebird Bio Inc (BLUE) Following Impressive Phase 1 Interim Results in Relapse/Refractory Multiple Myeloma

bluebird bio Inc (NASDAQ:BLUE) shares are surging 25% after releasing interim results from the firm’s Phase 1 trial of its anti-BCMA CAR T …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts